Research has revealed a notable association between the manifestation of PD-L1 and CTLA-4 and the presence of cancer stem cell (CSC)-like properties, including elevated levels of CD44 and/or CD133 expression on neoplastic cells [7,33]. The gene discussed is CD44; the disease is cancer.